ArticleAIDS research and human retroviruses2013

Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects.

Charles Hicks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.